- Home
- ESPR vs BLW Comparison
ESPR vs BLW Comparison
Compare ESPR & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- BLW
- Stock Information
- Founded
- ESPR 2008
- BLW 2003
- Country
- ESPR United States
- BLW United States
- Employees
- ESPR N/A
- BLW N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- BLW Other Consumer Services
- Sector
- ESPR Health Care
- BLW Consumer Discretionary
- Exchange
- ESPR Nasdaq
- BLW Nasdaq
- Market Cap
- ESPR 534.3M
- BLW 546.5M
- IPO Year
- ESPR 2013
- BLW N/A
- Fundamental
- Price
- ESPR $2.55
- BLW $14.12
- Analyst Decision
- ESPR Buy
- BLW
- Analyst Count
- ESPR 6
- BLW 0
- Target Price
- ESPR $6.50
- BLW N/A
- AVG Volume (30 Days)
- ESPR 7.0M
- BLW 85.9K
- Earning Date
- ESPR 11-06-2025
- BLW 01-01-0001
- Dividend Yield
- ESPR N/A
- BLW 8.83%
- EPS Growth
- ESPR N/A
- BLW N/A
- EPS
- ESPR N/A
- BLW 1.81
- Revenue
- ESPR $268,125,000.00
- BLW N/A
- Revenue This Year
- ESPR $13.05
- BLW N/A
- Revenue Next Year
- ESPR N/A
- BLW N/A
- P/E Ratio
- ESPR N/A
- BLW $7.73
- Revenue Growth
- ESPR N/A
- BLW N/A
- 52 Week Low
- ESPR $0.69
- BLW $12.35
- 52 Week High
- ESPR $3.94
- BLW $14.26
- Technical
- Relative Strength Index (RSI)
- ESPR 47.71
- BLW 49.36
- Support Level
- ESPR $2.35
- BLW $13.89
- Resistance Level
- ESPR $3.41
- BLW $14.14
- Average True Range (ATR)
- ESPR 0.18
- BLW 0.07
- MACD
- ESPR -0.03
- BLW -0.01
- Stochastic Oscillator
- ESPR 9.79
- BLW 60.85
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.